In a preclinical model of 4T1 breast-tumor-bearing BALB/c mice, PU-WS13 decreased CD206-expressing M2-like macrophages in the tumor microenvironment, reduced tumor growth and collagen content, and increased the recruitment of CD8+ cells in the tumor microenvironment [145]. The gene discussed is CD8A; the disease is neoplasm.